Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-20 Sale | 2024-02-21 5:52 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 162,500 | $12 | $1,950,000 | 19,201,475 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:14 pm | Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer | 9,138 | $12.59 | $115,052 | 1,535,167 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:09 pm | Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel | 2,776 | $12.59 | $34,951 | 43,981 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:08 pm | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 3,725 | $12.59 | $46,900 | 132,397 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:04 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 8,371 | $12.59 | $105,395 | 119,478 (Direct) | View |
| 2023-11-01 Sale | 2023-11-02 4:49 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 7,507 | $8.3914 | $62,994 | 81,250 (Direct) | View |
| 2023-10-13 Purchase(A) | 2023-10-17 7:41 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Davis Aaron I. LEWIS JOSEPH MVA Investors LLC Boxer Asset Management Inc. See remarks | 1,250,000 | $6.978 | $8,722,500 | 15,912,577 (Indirect Direct) | View |
| 2023-10-13 Purchase | 2023-10-17 6:04 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Davis Aaron I. LEWIS JOSEPH MVA Investors LLC Boxer Asset Management Inc. See remarks | 1,250,000 | $6.978 | $8,722,500 | 15,912,577 (Indirect Direct) | View |
| 2023-10-09 Sale | 2023-10-11 9:22 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks | 225,000 | $9.9567 | $2,240,250 | 14,662,577 (Indirect Direct) | View |
| 2023-08-11 Purchase | 2023-08-15 9:34 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks | 475,000 | $5.15 | $2,446,250 | 17,228,192 (Indirect Direct) | View |
| 2022-10-11 Purchase | 2022-10-13 9:30 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. 10% Owner | 237,000 | $4.4075 | $1,044,573 | 7,123,642 (Direct) | View |
| 2022-10-04 Purchase | 2022-10-06 9:15 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH 10% Owner | 182,000 | $3.9236 | $714,096 | 7,053,642 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-01 Option Award | 2024-02-05 4:27 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 275,888 | $0 | 275,888 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:22 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 326,192 | $0 | 326,192 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:21 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer | 610,180 | $0 | 610,180 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:19 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel | 160,015 | $0 | 160,015 (Direct) | View |
Ownership | 2023-10-16 3:42 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 13,330,736 (Indirect) | View |
| 2023-08-11 Option Award(A) | 2023-10-11 7:22 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks | 2,340,579 | $5.1499 | 17,228,174 (Direct) | View |
| 2023-08-11 Option Award(A) | 2023-10-11 7:22 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. See remarks | 475,000 | $5.15 | 17,228,174 (Indirect) | View |
| 2023-08-29 Option Award | 2023-08-31 4:07 pm | N/A 2033-08-29 | Tango Therapeutics Inc. | TNGX | Ketchum John B Director | 70,000 | $0 | 70,000 (Direct) | View |
Ownership | 2023-08-22 4:15 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Third Rock Ventures VI L.P. Third Rock Ventures GP VI L.P. TRV GP VI LLC Director | 0 | $0 | 194,174 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:40 pm | N/A 2033-06-06 | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:39 pm | N/A 2033-06-06 | Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:36 pm | N/A 2033-06-06 | Tango Therapeutics Inc. | TNGX | Borisy Alexis Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:34 pm | N/A 2033-06-06 | Tango Therapeutics Inc. | TNGX | Huber Reid M Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:33 pm | N/A 2033-06-06 | Tango Therapeutics Inc. | TNGX | Peters Malte Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 9:32 pm | N/A 2023-06-06 | Tango Therapeutics Inc. | TNGX | Davis Aaron I. Director | 35,000 | $0 | 14,415,616 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:10 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 568,750 | $0 | 568,750 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:06 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer | 626,818 | $0 | 1,994,410 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:06 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 229,893 | $0 | 293,760 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:06 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel | 167,289 | $0 | 167,289 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:05 pm | N/A 2033-03-01 | Tango Therapeutics Inc. | TNGX | Huang Alan Chief Scientific Officer | 221,878 | $0 | 357,765 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 4:10 pm | N/A 2032-12-01 | Tango Therapeutics Inc. | TNGX | Weitzman Aaron Chief Medical Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-28 4:31 pm | N/A 2032-06-08 | Tango Therapeutics Inc. | TNGX | Borisy Alexis Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-28 4:30 pm | N/A 2032-06-08 | Tango Therapeutics Inc. | TNGX | Davis Aaron I. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-28 4:29 pm | N/A 2032-06-08 | Tango Therapeutics Inc. | TNGX | Peters Malte Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-28 4:28 pm | N/A 2032-06-08 | Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director | 40,000 | $0 | 40,000 (Direct) | View |